The activity of caspases in spontaneous and camptothecin-induced death of melanotic and amelanotic melanoma cell.
Loss of pigment in hamster amelanotic melanoma line is accompanied by a faster growth rate, higher tumorigenicity and shorter animal survival time. Thus, the malignancy of melanoma increases during the alteration of melanotic (Ma) into amelanotic (Ab) line. As changes in the ability to undergo a spontaneous or induced apoptosis, and the role of caspases in this process during melanoma progression are not well defined, they were investigated in this work. Our results show that the proportion of spontaneously early apoptotic (caspase+/PI-) cells in the Ab line decreased in comparison to the Ma line. Cytochrome c release into cytosol, and the activation of effector caspases, estimated by PARP degradation clearly showed that during the spontaneous death in the cells from both melanoma lines intrinsic way of apoptosis was activated. Confocal and cytometric flow analyses indicate that camptothecin (CPT) induced apoptosis with caspase activation by the intrinsic way only in the amelanotic melanoma cells, even though cells of the Ma line also underwent CPT-induced apoptosis (the content of TUNEL-positive cells increased). Thus, our results suggest that melanoma progression, associated with a decreased ability to undergo spontaneous apoptosis but an increased susceptibility to CPT-induced apoptosis, relates to different levels of caspase activation; they also show that intrinsic way of apoptotis depends on the phenotype of melanoma cells, being more pronounced in the melanotic melanoma cells. On the other hand, melanotic melanoma cells resistance to camptothecin-induced apoptosis suggests that the melanogenic apparatus or melanin itself may have the protective effect on the ability of the melanoma cells to undergo apoptosis.
Cichorek
Miroslawa
M
Department of Embryology, Medical University of Gdansk, Gdansk, Poland. cichorek@amg.gda.pl
Kozłowska
Krystyna
K
Bryl
Ewa
E
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity; D017209:Apoptosis; D002166:Camptothecin / Q000633:toxicity; D020169:Caspases / Q000032:analysis / Q000378:metabolism*; D045744:Cell Line, Tumor; D006224:Cricetinae; D045304:Cytochromes c / Q000378:metabolism; D018450:Disease Progression; D005434:Flow Cytometry; D008297:Male; D008543:Melanins / Q000378:metabolism; D018328:Melanoma, Amelanotic / Q000201:enzymology* / Q000473:pathology; D008546:Melanoma, Experimental / Q000201:enzymology* / Q000473:pathology; D008647:Mesocricetus; D018613:Microscopy, Confocal; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D012878:Skin Neoplasms / Q000201:enzymology* / Q000473:pathology
D000970:Antineoplastic Agents; D008543:Melanins; D045304:Cytochromes c; D011065:Poly(ADP-ribose) Polymerases; D020169:Caspases; D002166:Camptothecin